Clinical trial
Aripiprazole in the Treatment of Tourette's Syndrome
NCT00282139 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aripiprazole in the Treatment of Tourette's Syndrome
- Lead sponsor
- University of Florida
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- January 31, 2004
- Completion date
- October 31, 2006
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
tourette's syndrome